Nucleosides and nucleotides. 123. Synthesis of 1-(2-deoxy-2-isocyano-.beta.-D-arabinofuranosyl)cytosine and related nucleosides as potential antitumor agents
1993; American Chemical Society; Volume: 36; Issue: 26 Linguagem: Inglês
10.1021/jm00078a007
ISSN1520-4804
AutoresAkira Matsuda, Akihito Dan, Noriaki Minakawa, Scott James Tregear, Shinji Okazaki, Yoshikazu Sugimoto, Takuma Sasaki,
Tópico(s)HIV/AIDS drug development and treatment
ResumoADVERTISEMENT RETURN TO ISSUEPREVArticleNEXTNucleosides and nucleotides. 123. Synthesis of 1-(2-deoxy-2-isocyano-.beta.-D-arabinofuranosyl)cytosine and related nucleosides as potential antitumor agentsAkira Matsuda, Akihito Dan, Noriaki Minakawa, Scott James Tregear, Shinji Okazaki, Yoshikazu Sugimoto, and Takuma SasakiCite this: J. Med. Chem. 1993, 36, 26, 4190–4194Publication Date (Print):December 1, 1993Publication History Published online1 May 2002Published inissue 1 December 1993https://pubs.acs.org/doi/10.1021/jm00078a007https://doi.org/10.1021/jm00078a007research-articleACS PublicationsRequest reuse permissionsArticle Views123Altmetric-Citations7LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstractCitation and referencesMore Options Share onFacebookTwitterWechatLinked InRedditEmail Other access optionsGet e-Alertsclose Get e-Alerts
Referência(s)